Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasoactive peptides in Bartter's syndrome

M M Stahl1, I Vaara, P Hedner

  • 1Department of Clinical Pharmacology, Lund University Hospital, Sweden.

European Journal of Clinical Investigation
|February 1, 1993
PubMed
Summary

Patients with Bartter's syndrome show elevated levels of vasoconstrictors like noradrenaline and neuropeptide Y, potentially impacting blood pressure regulation. Further research is needed to clarify the role of substance P and overall clinical significance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relativistic kinetic theory for spin-1/2 particles: Conservation laws, thermodynamics, and linear waves.

Physical review. E·2019
Same author

Equestrian-related injuries, predictors of fatalities, and the impact on the public health system in Sweden.

Public health·2019
Same author

Relativistic kinetic equation for spin-1/2 particles in the long-scale-length approximation.

Physical review. E·2017
Same author

Electromagnetic hypersensitive Finns: Symptoms, perceived sources and treatments, a questionnaire study.

Pathophysiology : the official journal of the International Society for Pathophysiology·2013
Same author

Neuropeptide levels in Dercum's disease (adiposis dolorosa).

Reumatismo·2012
Same author

Reducing electromagnetic irradiation and fields alleviates experienced health hazards of VDU work.

Pathophysiology : the official journal of the International Society for Pathophysiology·2012

Area of Science:

  • Endocrinology
  • Nephrology
  • Cardiovascular Physiology

Background:

  • Bartter's syndrome is characterized by vascular unresponsiveness to pressor agents like angiotensin II and noradrenaline.
  • High urinary prostaglandins suggest increased renal prostaglandin production, potentially mediating this unresponsiveness.
  • The role of various vasoactive peptides in Bartter's syndrome pathophysiology remains unclear.

Purpose of the Study:

  • To investigate the basal plasma levels of vasoactive peptides and catecholamines in Bartter's syndrome.
  • To determine if altered peptide levels contribute to blood pressure regulation in this condition.

Main Methods:

  • Analysis of basal immunoreactive plasma levels of vasoactive peptides and catecholamines.
  • Comparison of levels in six Bartter's syndrome patients versus healthy subjects.

Related Experiment Videos

Main Results:

  • Significantly increased plasma levels of noradrenaline (NA), adrenaline (A), and neuropeptide Y-like immunoreactivity (NPY-LI) were observed in Bartter's syndrome patients.
  • Elevated plasma levels of the vasodilator substance P-like immunoreactivity (SP-LI) were also noted.
  • P-values: NA (0.030), A (0.046), NPY-LI (0.001), SP-LI (0.057).

Conclusions:

  • Bartter's syndrome may involve enhanced vasoconstriction due to increased catecholamine and NPY release.
  • The role of substance P as a vasodilator in this context requires further investigation.
  • The clinical significance of these biochemical findings for blood pressure maintenance in Bartter's syndrome needs to be determined.